查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417982

生物分子软体市场报告：2030 年趋势、预测与竞争分析

Biomolecule Software Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物分子软体趋势与预测

预计 2024 年至 2030 年，全球生物分子软体市场将以 15.0% 的复合年增长率成长。该市场的主要驱动力是药物研发和市场开拓中对生物分子软体的需求不断增长以及个人化医疗的日益采用。全球生物分子软体市场的未来充满希望，医院、诊所和研究中心市场充满机会。

生物分子软体市场洞察

Lucintel 预测，由于 Windows 的易用性以及与现有基础设施的兼容性，Windows 在预测期内将出现最高的成长。

由于分析患者资料、确定药物研发标靶和製定个人化治疗计划的需求不断增加，预计医院将在市场上实现最高成长。

由于其强大的製药和生物技术产业，北美在预测期内仍将是最大的地区。

常问问题

Q1. 生物分子软体市场的成长预测如何？

A1. 2024年至2030年，全球生物分子软体市场预计将以15.0%的复合年增长率成长。

Q2.影响生物分子软体市场成长的关键驱动因素是什么？

A2. 该市场的主要驱动力是药物研发和市场开拓中对生物分子软体的需求不断增长以及个人化医疗的日益采用。

Q3.生物分子软体市场的主要部分是什么？

A3. 生物分子软体市场的未来性广阔，医院、诊所和研究中心市场都有机会。

Q4. 生物分子软体市场的主要企业有哪些？

A4.主要的生物分子软体公司如下。

  • Hamilton Thorne
  • Hermes Medical Solution
  • INDICAL BIOSCIENCE
  • Lexogen

Q5. 未来哪个细分领域将成为生物分子软体市场最大的领域？

A5.Lucintel 预测，由于易于使用以及与现有基础设施的兼容性，Windows 将在预测期内实现最高成长。

Q6. 未来五年生物分子软体市场预计在哪个地区成长最快？

A6. 由于製药和生技产业的实力，北美在预测期内将继续成为最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球生物分子软体市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物分子软体市场趋势（2018-2023）与预测（2024-2030）
  • 按功能类型分類的全球生物分子软体市场
    • Windows
    • Linux
    • MacOS
  • 全球生物分子软体市场（按应用）
    • 医院
    • 诊所
    • 研究中心

第四章 2018-2030年市场趋势及预测分析：分地区

  • 全球生物分子软体市场（按地区）
  • 北美生物分子软体市场
  • 欧洲生物分子软体市场
  • 亚太地区生物分子软体市场
  • 其他地区生物分子软体市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按功能类型分類的全球生物分子软体市场成长机会
    • 全球生物分子软体市场成长机会（按应用）
    • 全球生物分子软体市场按地区成长机会
  • 全球生物分子软体市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球生物分子软体市场的产能扩张
    • 全球生物分子软体市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Hamilton Thorne
  • Hermes Medical Solution
  • INDICAL BIOSCIENCE
  • Lexogen
简介目录

Biomolecule Software Trends and Forecast

The future of the global biomolecule software market looks promising with opportunities in the hospital, clinic, and research center markets. The global biomolecule software market is expected to grow with a CAGR of 15.0% from 2024 to 2030. The major drivers for this market are increasing demand for biomolecule software in drug discovery and development and growing adoption of personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Biomolecule Software by Segment

The study includes a forecast for the global biomolecule software by function type, application, and region.

Biomolecule Software Market by Function Type [Shipment Analysis by Value from 2018 to 2030]:

  • Windows
  • Linux
  • Macos

Biomolecule Software Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Clinic
  • Research Center

Biomolecule Software Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biomolecule Software Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomolecule software companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomolecule software companies profiled in this report include-

  • Hamilton Thorne
  • Hermes Medical Solution
  • Indical Bioscience
  • Lexogen

Biomolecule Software Market Insights

Lucintel forecasts that window is expected to witness the highest growth over the forecast period due to ease of use and compatible with existing infrastructure.

Within this market, hospital is expected to witness the highest growth due to growing demand for analyzing patient data, identifying drug targets, and developing personalized treatment plans.

North America will remain the largest region over the forecast period due to strong pharmaceutical and biotechnology industry.

Features of the Global Biomolecule Software Market

Market Size Estimates: Biomolecule software market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomolecule software market size by various segments, such as by function type, application, and region in terms of value ($B).

Regional Analysis: Biomolecule software market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different function types, applications, and regions for the biomolecule software market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomolecule software market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for biomolecule software market?

Answer: The global biomolecule software market is expected to grow with a CAGR of 15.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the biomolecule software market?

Answer: The major drivers for this market are increasing demand for biomolecule software in drug discovery and development and growing adoption of personalized medicine.

Q3. What are the major segments for biomolecule software market?

Answer: The future of the biomolecule software market looks promising with opportunities in the hospital, clinic, and research center markets.

Q4. Who are the key biomolecule software market companies?

Answer: Some of the key biomolecule software companies are as follows.

  • Hamilton Thorne
  • Hermes Medical Solution
  • Indical Bioscience
  • Lexogen

Q5. Which biomolecule software market segment will be the largest in future?

Answer: Lucintel forecasts that window is expected to witness the highest growth over the forecast period due to ease of use and compatible with existing infrastructure.

Q6. In biomolecule software market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to strong pharmaceutical and biotechnology industry.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biomolecule software market by function type (windows, linux, and macos), application (hospital, clinic, and research center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomolecule Software Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biomolecule Software Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biomolecule Software Market by Function Type
    • 3.3.1: Windows
    • 3.3.2: Linux
    • 3.3.3: MacOS
  • 3.4: Global Biomolecule Software Market by Application
    • 3.4.1: Hospital
    • 3.4.2: Clinic
    • 3.4.3: Research Center

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biomolecule Software Market by Region
  • 4.2: North American Biomolecule Software Market
    • 4.2.2: North American Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.3: European Biomolecule Software Market
    • 4.3.1: European Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.3.2: European Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.4: APAC Biomolecule Software Market
    • 4.4.1: APAC Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.4.2: APAC Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.5: ROW Biomolecule Software Market
    • 4.5.1: ROW Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.5.2: ROW Biomolecule Software Market by Application: Hospital, Clinic, and Research Center

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biomolecule Software Market by Function Type
    • 6.1.2: Growth Opportunities for the Global Biomolecule Software Market by Application
    • 6.1.3: Growth Opportunities for the Global Biomolecule Software Market by Region
  • 6.2: Emerging Trends in the Global Biomolecule Software Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biomolecule Software Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomolecule Software Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hamilton Thorne
  • 7.2: Hermes Medical Solution
  • 7.3: INDICAL BIOSCIENCE
  • 7.4: Lexogen